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Semaphorins were originally identified as neuronal guidancemoleculesmediating their attractive or repulsive
signals by forming complexes with plexin and neuropilin receptors. Subsequent research has identified func-
tions for semaphorin signaling in many organs and tissues outside of the nervous system. Vital roles for sem-
aphorin signaling in vascular patterning and cardiac morphogenesis have been demonstrated, and impaired
semaphorin signaling has been associated with various human cardiovascular disorders, including persis-
tent truncus arteriosus, sinus bradycardia and anomalous pulmonary venous connections. Here, we review
the functions of semaphorins and their receptors in cardiovascular development and disease and highlight
important recent discoveries in the field.Introduction
Semaphorins are a large family of secreted or membrane-asso-
ciated glycoproteins that are highly conserved both structurally
and functionally throughout evolution from viruses to mamma-
lians. Semaphorins and neuropilin receptors were initially identi-
fied as axon guidance molecules in the developing nervous
system (He and Tessier-Lavigne, 1997; Luo et al., 1993). Subse-
quently, semaphorins have been shown to function in a wide
range of developmental, physiological, and pathological pro-
cesses outside of the central nervous system, including lympho-
cyte activation, neural crest cell migration, vascular endothelial
cell motility, bone growth, tumor angiogenesis and progression,
lung branching morphogenesis, and cardiovascular develop-
ment (Cora` et al., 2014; Kruger et al., 2005; Neufeld and Kessler,
2008; Neufeld et al., 2012; Roth et al., 2009).
Semaphorin signals act by juxtacrine, paracrine, and autocrine
mechanisms to modulate cellular behavior and are categorized
into eight classes according to their structural features and spe-
cies of origin (Kruger et al., 2005). Class 1 and 2 semaphorins are
found in invertebrates, classes 3–7 are found in vertebrates, and
class 8 semaphorins are encoded by viruses (Figure 1). Though
semaphorins differ in their amino acid sequence and overall
structural characteristics, all members of the family contain a
conserved 500 aa ‘‘sema’’ domain located near the amino ter-
minus of themature protein. The sema domain is essential for re-
ceptor binding specificity and signaling (He and Tessier-Lavigne,
1997; Koppel et al., 1997). The sema domains of several different
semaphorins were recently characterized by mutagenesis, X-ray
crystallography, and 3D modeling, which reveals that the sema
domain is a variant of the seven blade b-propeller fold with over-
all structural similarities to the b-propeller repeats of a-integrins
(Siebold and Jones, 2013).
The different classes of semaphorins are characterized by
class-specific structural motifs. For example, classes 2–4 and
7 contain a single copy of an immunoglobulin-like domain, while
class 5 semaphorins contain seven copies of a thrombospondin
domain. All vertebrate and invertebrate semaphorins contain a
plexin-semaphorin-integrin (PSI) domain that is required for ho-modimerization (Klostermann et al., 1998). Another important
feature that differs between different semaphorin classes is the
presence of membrane anchoring sequences. Classes 2 and 3
semaphorins are produced as secreted proteins, whereas clas-
ses 1, 4, 5, and 6 are intrinsic membrane proteins and class 7
semaphorins are membrane anchored proteins, which can be
further processed into soluble proteins by proteolytic cleavage
(Figure 1) (Siebold and Jones, 2013).
Two families of semaphorin receptors have been identified:
plexins and neuropilins (Figure 1; Tables 1 and 2). The plexins
are a conserved family of large proteins (200 kDa), initially iden-
tified as cell surface molecules mediating cell adhesion (Ohta
et al., 1995). Nine members have been identified in vertebrates
that are divided into four classes: class A (plexin A1, A2, A3,
and A4), class B (plexin B1, B2, and B3), class C (plexin C1),
and class D (plexin D1) (Tamagnone et al., 1999). Unlike sema-
phorins, plexin architecture is conserved throughout the family.
The extracellular domain of plexins contains one sema domain
followed by three PSI and three Ig-like, plexin, and transcription
factor (IPT) repeats (Kruger et al., 2005). The sema domain acts
as an autoinhibitory element modulating plexin activation in
addition to its role in binding ligand (Figure 1). For example,
plexin A1 (Plxna1) mutants lacking the sema domain are consti-
tutively active, suggesting that the sema domain is necessary to
maintain Plxna1 in its basal inactive state (Takahashi and Stritt-
matter, 2001). The IPT domain plays an important role in pro-
tein-protein interaction (Watarai et al., 2008).
The intracellular domains of plexins contain two segments that
show sequence similarity to Ras-family-specific guanosine tri-
phosphatase (GTPase)-activating proteins (RasGAP). These
segments fold to form an intact GAP domain highly similar to
the GAP domain of p120 RasGAP (Siebold and Jones, 2013).
The GAP domains are separated by a linker region that includes
a Rho GTPase-binding domain (RBD). Three Rho family
GTPases, Rac1, Rnd1, and RhoD have been shown to bind the
RBD of plexin receptors (Tong et al., 2007). Mutation of the
two conserved arginine residues that correspond to the invariant
catalytic residues of Ras GAPs abolish plexin-mediated cellularCell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 163
Figure 1. Structure of Semaphorins and
Their Receptors
Semaphorins are categorized into eight classes
based on their structural features and species
origin. Semaphorins are defined by the presence
of a conserved ‘‘sema’’ domain near the N termi-
nus of the protein. Class 1 and 2 semaphorins are
found in invertebrates, Class 3–7 in vertebrates,
and SemaV in certain viruses. Semaphorins are
secreted (Sema2a-2b, Sema3a-3g, and SemaV),
membrane-bound (Sema1a-1b, Sema4a-4g,
Sema5a-5b, and Sema6a-6d), or GPI-anchored
proteins (Sema7a). Two distinct transmembrane
receptor families have been identified as sem-
aphorin receptors: plexins and neuropilins. Shown
here are the eleven members of the plexin family,
including the invertebrate plexins (Plexin A and
Plexin B) and the two members of the neuropilin
family. Generally, membrane-bound semaphorins
(class 4–7) directly bind to plexins. However, most
secreted semaphorins (class 3) require neuropilins
(Nrp1 and Nrp2) as binding co-receptors to enable
binding to plexins. Neuropilins provide binding
specificity for the class 3 semaphorins, whereas
plexins, which also contain a sema domain, serve
as signaling partners. An exception to this rule is
Sema3e, a secreted semaphorin that can directly
binds to plexinD1. Sema7a, a GPI-anchored
semaphorin, signals through integrin receptors.
Vegfr2 can form a receptor complex with plexin A1
that is required for Sema6d-mediated signaling in
cardiac development. Class 4 and 5 semaphorins
are associated with plexin B1-3 receptors, and the
receptor tyrosine kinases Met and Erbb2 can
function as coreceptors with plexin Bs for certain
class 4 semaphorins. Protein domains are indi-
cated: GAP, GTPase-activating protein; Ig-like,
immunoglobulin like; PSI, plexin semaphorin in-
tegrin; IPT, Ig-like plexin transcription factors;
CUB, complement C1r/C1s, Uegf, Bmp1; FV/VIII,
coagulation factor V/VIII homology like; MAM,
meprin like.
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are essential for plexin signaling. Accumulating evidence sug-
gests that activation of the GAP activity of plexins requires two
simultaneous events: binding of a semaphorin ligand to the
extracellular domain and binding of a Rho GTPase to the RBD
(Wang et al., 2012). Recently, crystal structures of the RBDs of
various plexin receptors demonstrated that this region has a
ubiquitin-like fold, which is also present in RasGAPs (Tong and
Buck, 2005). Although plexins share structural homology with
tyrosine kinase receptors such as c-Met, they do not exhibit tyro-
sine kinase activity, and details of downstream signaling events
remain to be fully elucidated.
Most membrane-bound semaphorins bind directly to the
plexin receptors. However, this is generally not the case with
(class 3) semaphorins, with the exception of semaphorin 3e
(Sema3e), which require an initial interaction with a neuropilin
co-receptor (Nrp1/Nrp2) to transduce their signal to plexin
receptors (Gu et al., 2003). Neuropilins are promiscuous co-re-
ceptors regarding both ligands and receptor partners that
participate in a broad range of signaling pathways (Gu et al.,
2003; Hillman et al., 2011; Muders, 2011; Neufeld et al., 2002;
Rizzolio and Tamagnone, 2011). Importantly with regard to the
cardiovascular system, neuropilins can partner with the vascular
endothelial growth factor (Vegf) receptor to mediate angiogenic
Vegf signaling to endothelial cells.164 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.Below, we highlight the recent advances in the field of sema-
phorin-plexin signaling in cardiovascular development and
contributions to congenital cardiac diseases. Cardiovascular ab-
normalities associated with defective semaphorin signaling are
summarized in Tables 1 and 2.
Cardiovascular Development: An Overview
The heart is the first functional organ to form during embryogen-
esis. Heart development (Figure 2) begins with the migration of
mesodermal precursors away from the primitive streak to form
a bow-shaped structure called the cardiac crescent. This region
can be divided into the first heart field, which gives rise to the
linear heart tube, and the second heart field, which gives rise
to portions of the atria, the outflow tract, and the right ventricle
(Epstein, 2010). Initially, the heart consists of two layers: an inner
endocardium and an outer myocardium. Subsequently, the
myocardial layer expands and proepicardial progenitor cells
migrate over the surface of the heart, contribute fibroblasts
that invade the myocardial layer, and form the outermost epicar-
dial layer. Complex asymmetric morphogenetic movements
coupled with uneven growth rates contribute to looping and
chamber formation. A series of septation events results in a fully
functional four-chambered heart integrated with systemic and
pulmonary circulations (Epstein, 2010). This process is facilitated
by neural crest cells, which migrate from the dorsal neural tube
and invade the cardiac outflow tract, contributing to the smooth
Table 1. Semaphorin Ligand Mutants with Cardiovascular Defects
Mutation(s) Receptors or Ligands Stage of Lethality Cardiovascular Phenotypes and Functions References
Semaphorins
Sema3a/ Plexin A1-A4, D1,
Nrp1-2, Vegfr2
Postnatal Atrial defects, sinus bradycardia, lymphatic
valve defects, vascular patterning defects.
Sema3a inhibits angiogenesis.
Bouvre´e et al., 2012; Chen et al.,
2013; Ieda et al., 2007; Jurisic
et al., 2012
Sema3b/ Plexin A1-A4, Nrp1-2,
Vegfr2
Viable No obvious cardiac defects. Sema3b inhibits
angiogenesis.
Falk et al., 2005
Sema3c/ Plexin A2, D1, Nrp1-2 Postnatal (varies
with strain)
PTA, VSD, aortic arch defects. Sema3c
promotes angiogenesis.
Feiner et al., 2001
Sema3d/ Nrp1 Viable APVC, ASD. Sema3d repels pulmonary vein
endothelial cells.
Degenhardt et al., 2013a; Katz
et al., 2012
Sema3e/ Plexin As (neuropilin
dependent), Plexin D1
Viable Vascular patterning defects. Sema3e restricts
blood vessel growth to the intersomitic
boundaries. Inhibits angiogenesis. A 61-kDa
Sema3e isoform promotes endothelial cell
migration.
Casazza et al., 2010; Gu et al.,
2005
Sema3f/ Plexin A3, A4, Nrp1-2 Viable No obvious phenotype. Sema3f inhibits
angiogenesis and lymphangiogenesis.
Sahay et al., 2003
Sema3g/ Nrp1-2 Viable Vascular remodeling defects. Sema3g
promote angiogenesis.
Kutschera et al., 2011
Sema4a/ Plexin B1-3, Plexin D1,
Met, Erbb2
Viable Enhanced angiogenesis in response to
Vegf or inflammatory stimuli. Sema4a
inhibits angiogenesis.
Kumanogoh et al., 2005; Toyofuku
et al., 2007
Sema4d/ Plexin B1-2, C1, Met,
Erbb2
Viable Delayed atherosclerotic plaque formation
due to impaired neovascularization.
Sema4d promotes angiogenesis.
Yukawa et al., 2010; Zhu et al.,
2009
Sema5a/ Plexin A3, B3, Nrp2,
Met, Erbb2
Viable or
embryonic
Defective cranial blood vessel remodeling.
Sema5a promotes angiogenesis.
Fiore et al., 2005; Matsuoka et al.,
2011
Sema6a/ Plexin A1, A2, A4,
Vegfr2
Viable Abnormal retinal vascular development.
Sema6a promotes angiogenesis. A soluble
form of Sema6a inhibits angiogenesis.
Segarra et al., 2012
Sema6d/ Plexin A1 Viable No obvious phenotype in mice. Sema6d
modulates compact layer expansion and
trabeculation in chick.
Takamatsu et al., 2010; Toyofuku
et al., 2004a, 2004b
VSD, ventricular septal defect; PTA, persistent truncus arteriosus; ASD, atrial septal defect.
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tion of the heart.
As the heart is forming, endothelial progenitor cells coalesce to
form a primitive vascular plexis and connect with one another to
form tubes (vasculogenesis) (Figure 3). The growing vessels
branch, expand, andmigrate (angiogenesis) in stereotypical pat-
terns under the influence of extrinsic growth factors such as Vegf
and various guidancemolecules, including semaphorins. Arterial
and venous endothelium adopt unique identities and gene
expression characteristics. The lymphatic vasculature emerges
from the venous vessels, including the cardinal vein at around
E10.5 in the mouse, and matures into a characteristically
patterned vascular system that drains extracellular fluid and
cellular constituents from organs and peripheral tissues, return-
ing lymph to the venous systemic system (Tammela and Alitalo,
2010).
Over the past several years, a growing body of literature impli-
cates semaphorin signaling in many aspects of cardiovascular
development (Tables 1 and 2), and a growing number of human
disorders are being associated with genetic mutation or variation
in semaphorin signaling pathway genes.Myocardial Compaction and Trabeculation
An essential process in cardiac development is chamber matu-
ration, and defects with this can lead to a variety of congenital
abnormalities including non-compaction, systolic dysfunction,
diastolic dysfunction, and arrhythmia (Teekakirikul et al., 2013).
During chamber development the myocardium consists of two
layers: an outer compact and an inner trabeculated layer. The
trabeculated myocardium is covered by the endocardium, and
the interaction between these two layers is essential for cardio-
myocyte proliferation and differentiation. Left ventricular non-
compaction (LVNC) is awell-studied cardiacmaturation disorder
characterized by extensively trabeculatedmyocardium of the left
ventricle and a thin compact zone (Oechslin and Jenni, 2011).
LVNC can lead to heart failure, stroke, ventricular arrhythmias,
and/or sudden cardiac death (Bhatia et al., 2011; Ichida et al.,
1999; Paterick and Tajik, 2012).
Toyofuku et al. (2004a, 2004b) demonstrated that the
Sema6d-Plxna1 interaction is required for cardiac chamber
developmentSema6d is expressed in compact and trabeculated
myocardial cells; however, its receptor Plxna1 is expressed by
trabeculated myocardial and endocardial cells (Toyofuku et al.,Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 165
Table 2. Semaphorin Receptor Mutants with Cardiovascular Defects
Mutation(s) Receptors or Ligands Stage of Lethality Cardiovascular Phenotypes and Functions References
Plexins
Plxna1/ Sema3a, Sema5a or 5b,
Sema6c or 6d
Viable No obvious cardiac defects. Lymphatic
valves are abnormal.
Bouvre´e et al., 2012;
Takegahara et al., 2006
Plxna2/ Sema6a or 6b Viable PTA and lack of aortic and pulmonary
channel septation with incomplete
penetrance. Double knockouts lacking
Plxna2 and Plxna4 exhibit cardiovascular
defects with higher penetrance.
Suto et al., 2007;
Toyofuku et al., 2008
Plxna4/ Sema6a or 6b Viable Double knockouts lacking Plxna2 and
Plxna4 exhibit cardiovascular defects with
higher penetrance.
Toyofuku et al., 2008
Plxnd1/ and
Plxnd1ecKO
Sema3a, 3c (neuropilin
dependent) Sema3e, 4a
(neuropilin-independent)
Postnatal PTA, VSD, atrial defects, coronary artery
and aortic arch defects.
Gitler et al., 2004;
Zhang et al., 2009
Neuropilins
Nrp1/, Nrp1ecKO,
and Nrp1-Sema
Coreceptor for class 3
semaphorins and others
Embryonic E10.5-
12.5 Perinatal
Postnatal
Various cardiac and vascular defects
including PTA and aortic arch defects. PTA,
BAE, AOC, VSD. BAE, VSD, lymphatic
vessels and valve defects.
Gu et al., 2003;
Kawasaki et al., 1999
Nrp2/ Coreceptor for class 3
semaphorins and others
Viable Lymphatic vessel and capillary formation
defect.
Giger et al., 2000;
Yuan et al., 2002
Nrp1/; Nrp2/ Coreceptor for class 3
semaphorins and others
Embryonic (E8.0) Vascular anomalies in both embryos and
placenta.
Takashima et al., 2002
Nrp1Sema; Nrp2/ Coreceptor for class 3
semaphorins and others
Not reported PTA, BAE, AOC and VSD, no vascular
defects reported.
Gu et al., 2003
BAE, Bilateral atrial enlargement; AOC, anomalous origin of the coronary arteries; VSD, ventricular septal defect; PTA, persistent truncus arteriosus.
Cell Metabolism
Perspective2004a, 2004b). Knockdown of Sema6d, Plxna1, or both in chick
embryos results in a non-compaction phenotype characterized
by a thin, compact myocardium (Toyofuku et al., 2004a,
2004b). Further experiments suggest that membrane-bound
Sema6d can function as both a ligand and a receptor for Plxna1
to modulate compact layer expansion and trabeculation (Toyo-
fuku et al., 2004b). Surprisingly, Sema6d knockout mice are
viable and show no obvious cardiac defects (Takamatsu et al.,
2010). Additional roles for semaphorins in myocardial maturation
are likely. For example, Sema3a mutant mice display abnormal
right ventricular and atrial myocardium (Behar et al., 1996).
Neural Crest and Cardiac Outflow Tract Development
Many signaling pathways have been implicated in regulating
specification, induction, migration, proliferation, differentiation,
and survival of cardiac neural crest cells (High and Epstein,
2008; Stoller and Epstein, 2005). Disruption of cardiac neural
crest during development leads to specific forms of congenital
heart disease, including interruption of the aortic arch, persistent
truncus arteriosus (PTA), and double outlet right ventricle (DORV)
(Stoller and Epstein, 2005). Various studies have demonstrated
that semaphorin-plexin signaling can regulate the migration of
cardiac neural crest cells to the forming heart.
Sema3c is expressed in the OFT myocardium and branchial
archmesenchyme throughout the septation and remodeling pro-
cess (Feiner et al., 2001). Genetic deletion of Sema3c causes
postnatal lethality due to PTA, ventricular septal defects, and
interruption of the aortic arch. Molecular analysis reveals
abnormal migration of cardiac neural crest cells in Sema3c/
mouse embryos associated with anomalous expression of166 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.Foxc1, Ednra, and Plxna2 by neural crest (Feiner et al., 2001).
The OFT and aortic arch defects in Sema3c mutants are similar
to neural-crest-ablated chick embryos, suggesting that Sema3c
expression is essential for OFT development and aortic arch
patterning. Recent work in chick embryos suggests that cardiac
neural crest cell migration is determined by both repulsive and
attractive cues provided by semaphorins. Sema3c can provide
attractive cues while membrane-bound Sema6a and Sema6b
can provide repulsive cues to migrating neural crest (Toyofuku
et al., 2008). However, Sema3c is also expressed by migrating
cardiac neural crest and may signal to surrounding endothelium
expressing Plxnd1 and Nrp1/2, resulting in reciprocal signaling
cascades that ultimately affect neural crest patterning and differ-
entiation. Interestingly, Sema3c expression by cardiac neural
crest is Gata6 dependent, and Gata6 mutations in mice and hu-
mans are associated with congenital heart disease including
PTA (Kodo et al., 2009; Lepore et al., 2006).
A host of additional studies using genetically modified mice
further implicate semaphorin signaling in cardiac neural crest
and outflow tract development (Brown et al., 2001; Gitler et al.,
2004; Gu et al., 2003; Toyofuku et al., 2008; Zhang et al.,
2009). Plxna2, which may act as a receptor for Sema6a/b (Toyo-
fuku et al., 2008), is expressed by migrating cardiac neural crest
(Brown et al., 2001), and loss of expression in mice results in
impaired migration and cardiovascular abnormalities, including
PTA and lack of aortic and pulmonary artery septation (Toyofuku
et al., 2008). Loss of Plxna2 leads to the upregulation of plexin A4
(Plxna4) in the OFT, suggesting a compensatory response (Toyo-
fuku et al., 2008), and double mutants for Plxna2 and Plxna4
Figure 2. Cardiac Development
The heart originates from mesodermal cells in the primitive streak. During gastrulation, cardiac progenitors migrate to the splanchnic mesoderm to form the
cardiac crescent. At E7.5 in themouse, the cardiac crescent can be divided into two heart field lineages based on differential gene expression and their respective
contribution to heart, a first heart field (red) and a second heart field (yellow), which is located posteriorly andmedially to the first heart field. At E8.0, the linear heart
tube is present. At E8.5, the looping is associated with uneven growth of cardiac chambers. The outflow tract is at the arterial pole and the inflow tract and
primitive atria are at the venous pole. By E9.5, the common atrium has moved superior to the ventricles and is separated by a distinct atrio-ventricular canal. By
E10.5, cardiac neural crest cells from the dorsal neural tubemigrate via the pharyngeal arches to the cardiac outflow tract. Further cardiac development involves a
series of septation events and myocardial trabeculation that result in a mature four-chambered heart integrated with the circulatory system depicted at E15.5.
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(Toyofuku et al., 2008). Recently Li et al. (2013) demonstrated
that neural-crest-specific Plxna2 gene activation is Brg1
(Brahma-related gene 1) dependent. Brg1, an ATPase subunit
of the Brg1/BAF chromatin-remodeling complex, interacts at
the Plxna2 promoter with chromodomain-helicase-DNA-binding
protein 7 (Chd7), which is encoded by a genemutated in humans
with CHARGE syndrome characterized by OFT defects. Neural-
crest-specific Brg1 mutants also display defects in OFT forma-
tion (Li et al., 2013).
Plxnd1 is expressed by endothelial cells during cardiovascular
development (Gitler et al., 2004; Zhang et al., 2009). Plxnd1-null
pups and endothelial-specific Plxnd1 knockouts die shortly after
birth due with PTA, defective aortic arch arteries, and ventricular
septal defects (Gitler et al., 2004; Zhang et al., 2009). Mutations
of PLXND1 have been associated with isolated cases of truncus
arteriosus in humans (Ta-Shma et al., 2013). Recent work by
Worzfeld et al. (2014) demonstrates that transgenic mice
harboring mutations in the GAP domain of Plxnd1 recapitulate
the phenotype of Plxnd1-null mice, suggesting that the GAP
domain is essential for Plxnd1 signaling during cardiac develop-ment. Plxnd1 may interact with Nrp1 to transduce a Sema3c
signal (Toyofuku et al., 2008), but the spectrum of Plxnd1 ligands
has yet to be fully defined, and the mechanism by which loss of
Plxnd1 signaling in endothelium results in OFT defects remains
obscure. Given the known roles of Notch signaling in OFT forma-
tion (High and Epstein, 2008), it is attractive to hypothesize that
loss of Plxnd1 results in abnormal Notch signaling from endothe-
lium to surrounding mesenchyme, including neural crest, but this
hypothesis awaits experimental validation.
Cardiac defects similar to Sema3c, Plxna2, and Plxnd1 mu-
tants have been described in Nrp1 knockout (Kawasaki et al.,
1999) and endothelial-specific Nrp1 knockout mice (Gu et al.,
2003). However, PTA is not observed in mice expressing a form
of neuropilin-1 unable to bind class 3 semaphorins (Nrp1sema),
suggesting that sema-independent Nrp1 signaling in endothelial
cells is essential for OFT septation (Gu et al., 2003). Interestingly,
Nrp1semamice on aNrp2-null background do display PTA, sug-
gesting functional redundancy. SinceNrp1 can bind Vegf in addi-
tion to semaphorins, it is possible that Vegf-dependent Nrp1
signalingmodulatesOFTdevelopment accounting for these find-
ings.However,Guet al. (2003) recently reported thephenotypeofCell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 167
Figure 3. Schematic Overview of Mammalian Vascular Development
Vascular endothelial progenitor cells (angioblasts) are derived from mesodermal cells during gastrulation. These mesodermal cells have potential to give rise to
both blood and endothelium. However, their fate is restricted once they have emigrated into extra-embryonic tissue (extra embryonic ectoderm, yolk sac, and
allantois) and intra-embryonic tissues (embryonic ectoderm). In extra-embryonic tissue, these angioblasts aggregate to form blood islands. Fusion of blood
islands leads to the formation of a honeycomb-shaped primitive capillary plexus. However, in intra-embryonic tissue, angioblasts aggregate and directly form the
dorsal aorta and cardinal vein without a vascular plexus intermediate. The primitive vascular plexus along with dorsal aorta and cardinal vein undergo remodeling
to form a mature circulatory system. Lymphatic endothelial cells (LECs) are specified in embryonic cardinal veins at defined locations. Under the influence of
Vegfc, produced by the mesenchymal cells surrounding the cardinal veins, LEC precursors lose their polarity, delaminate from the veins, migrate, and aggregate
to form the primary lymph sacs. Furthermore, sprouting, remodeling, and expansion of the lymph sacs and primitive lymphatic plexus lead to the formation of
mature peripheral lymphatic vasculature. There are two types of lymphatic vessels: collecting lymphatic vessels and lymphatic capillaries. Lymphatic capillaries
are thin-walled, blind-ended vessels that absorb interstitial fluid and transport it to the collecting lymphatic vessels. Collecting lymphatic vessels are surrounded
by smooth muscle cells and have bicuspid valve to facilitate unidirectional lymphatic flow.
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abolish Vegf binding. The resulting Nrp1Vegf mice survive to
adulthood and do not display OFT defects (Gelfand et al.,
2014). The relative influence of Vegf versus semaphorin signaling
via neuropilins remains to be fully elucidated.
Epicardial Development
The epicardial layer of the heart is derived from a transient struc-
ture called the proepicardial organ (PEO) that arises from the
mesothelium of the septum transversum (Gittenberger-de Groot
et al., 1998; Ma¨nner et al., 2001; Mikawa and Fischman, 1992;
Mikawa and Gourdie, 1996). During embryonic development,
the epicardium provides progenitor cells that give rise to various
cardiac lineages, including fibroblasts, endothelial, and smooth
muscle, with important contributions to the coronary vasculature
(Limana et al., 2011; Singh and Epstein, 2012; Singh et al., 2011).
The epicardium also plays an important role in cardiac injury and
repair. Embryonic gene programs in the epicardium are acti-
vated after myocardial injury and factors are released from the
activated epicardium that affect cardiac repair and regeneration,
partly by modulating angiogenesis (Zhou et al., 2011).168 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.The proepicardial contribution to cardiac lineages has been
controversial, with conflicting findings in chick and mouse
models. The PEO is a heterogeneous tissue comprised of genet-
ically distinct sub-populations of progenitor cells with distinct
fates (Degenhardt et al., 2013b; Katz et al., 2012). One popula-
tion, capable of contributing to coronary endothelium, is charac-
terized by expression of Sema3d (M. Aghajanian, in press; Katz
et al., 2012). Additionally, Sema3d-expressing proepicardial
cells also contribute to the endothelial lining of the sinus veno-
sus, a tissue previously reported to contribute to coronary endo-
thelial cells (Katz et al., 2012; Red-Horse et al., 2010). Although
not yet directly demonstrated, it is likely that epicardial-derived
semaphorins function to pattern coronary vasculature and
innervation during development. These functions could also
contribute to epicardial signals that modulate the response to
injury in the adult.
Pulmonary Vein Patterning
The pulmonary veins function to return oxygenated blood from
the lungs to the left atrium. Inappropriate patterning of the pul-
monary veins during development can result in abnormal
Cell Metabolism
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tures that connects to the right atrium such as the coronary sinus
or vena cavae. This type of anomalous pulmonary venous
connection (APVC) can cause hypoxia and volume overload to
the right side of the heart, requiring surgical intervention if se-
vere. Little is known about the developmental signals that pattern
the pulmonary veins or about the genetic or environmental
causes of APVC in humans.
Sema3d-null mice exhibit APVC and have provided novel in-
sights into the developmental pathophysiology of pulmonary
venous malformations (Degenhardt et al., 2013a). As the pulmo-
nary veins form during mid-gestation, Sema3d is expressed in
the mesocardial reflections adjacent to the maturing vascular
plexus. Sema3d is thought to act as a repulsive guidance mole-
cule to constrain and direct the developing pulmonary venous
endothelial cells toward the left atrium. This is supported by
the ability of Sema3d to repel endothelial cells in vitro, and the
abnormal invasion of endothelial cells into the region where
Sema3d is normally expressed in the Sema3d nulls (Aghajanian
et al., 2014; Degenhardt et al., 2013a). Sema3d is able to bind to
the endothelial cells of the nascent pulmonary vein, which ex-
press Nrp1, and Nrp1 is required for Sema3d-mediated endo-
thelial repulsion (Aghajanian et al., 2014; Degenhardt et al.,
2013a). (Although Nrp1 has been suggested to be arterial spe-
cific [Herzog et al., 2001], more recent studies indicate that it is
also expressed by some venous and lymphatic endothelium [De-
genhardt et al., 2013a].)
Mutations or genetic variants of SEMA3D may account for
some cases of APVC in humans. In one case, a patient with
APVC was identified with a very rare variant (not found in several
thousand controls) resulting in a phenylalanine-to-leucine
(F602L) substitution (Degenhardt et al., 2013a). The mutation re-
sults in a significantly reduced ability to bind Nrp1 and to repel
endothelial cells in vitro. In the future, it will be of interest to inves-
tigate the potential contributions of genetic variants in both
SEMA3D and the genes encoding othermembers of the Sema3d
signaling cascade in APVC.
Autonomic Innervation of the Heart
Cardiac tissues are innervated by sympathetic and parasympa-
thetic nerve fibers that provide critical connections for regulation
of heart rate, contractility, and blood pressure in response to
changes in physiologic demand. The cardiac sympathetic
nerves, which are located subepicardially, stimulate heart rate,
while parasympathetic nerves are generally subendocardial
and function to inhibit heart rate (Zipes, 2008). The ventricular
sympathetic innervation is characterized by a gradient from
base to apex (Crick et al., 1994, 1999; Pierpont et al., 1985).
Specialized conduction tissues such as the sinoatrial node, atrio-
ventricular node, and His bundles are highly innervated
compared to the myocardium. Abnormal innervation can be
associated with lethal arrhythmias in diseased hearts (Cao
et al., 2000a, 2000b; Opthof et al., 1991).
Sema3a is initially expressed in the subendocardial cells of the
trabeculatedmyocardium of both ventricles. Later, it is restricted
to Purkinje fibers (specialized conduction cells) along the ventric-
ular wall. Through embryonic development, Sema3a expression
is consistent with a role in patterning the sympathetic innervation
in the heart (Ieda et al., 2007). Although the majority of Sema3a
knockout mice die within a week of birth, some survive pastweaning (Behar et al., 1996). In these animals, sympathetic car-
diac innervation is mis-patterned and results in a slow heart rate
(sinus bradycardia) (Ieda et al., 2007). Cardiac-specific overex-
pression of Sema3a significantly reduces sympathetic innerva-
tion suggesting a repulsive and inhibitory role for Sema3a in
neuronal growth and patterning. These Sema3a transgenic ani-
mals display spontaneous premature ventricular contractions
and an increased susceptibility to ventricular arrhythmias (Ieda
et al., 2007). Recently, Chen et al. (2013) reported that overex-
pression of Sema3a in border zone myocardium surrounding a
recent myocardial infarction can reduce hyper-innervation that
normally accompanies the response to injury, consequently
reducing susceptibility to ventricular tachycardia.
Recently, a genetic variant in the human SEMA3A gene was
associated with unexplained cardiac arrest and ventricular
arrhythmia (Nakano et al., 2013). A non-synonymous polymor-
phism (I334V, rs138694505A > G) was identified in the 10th
exon of the SEMA3A gene, and this variant was significantly
more common in a cohort of 83 Japanese patients diagnosed
with unexplained cardiac arrest than in 2,958 healthy controls.
Similar to Sema3a knockout mice, patients with this I334V
variant have abnormal patterning of sympathetic nerves and si-
nus bradycardia. The I334V variant protein has reduced activity
in a repulsion assay (Nakano et al., 2013).
Vascular Patterning
PlexinD1. Semaphorin signaling contributes to growth and
patterning of the entire vascular system, and the complexity and
redundancy by which these signals interact with each other
andwithother angiogenicpathways to influencenormal andpath-
ologic blood vessels is becoming increasingly apparent. Perhaps
themost visually dramatic and convincing evidence for the ability
of secreted class 3 semaphorins to guide growing endothelial
sprouts derives fromwork in zebrafish, where the emerging intra-
somitic blood vessels can be visualized in real-time. Knockdown
of plxnd1 expressed by endothelial cells, or of sema3a secreted
by adjacent somitic mesoderm, produces abnormally patterned
vessels with too many angiogenic sprouts due to loss of a repel-
lent guidance signal (Torres-Va´zquez et al., 2004).
Plxnd1 can probably respond tomultiple class 3 semaphorins.
It can bind Sema3e even in the absence of a neuropilin co-recep-
tor, and mouse knockouts of both Plxnd1 and Sema3e display
intersomitic vascular patterning defects (Gitler et al., 2004; Gu
et al., 2005). Sema3e-Plxnd1 signaling is also required for proper
dorsal aortae patterning in the early embryo (Meadows et al.,
2013). Plxnd1 can repress angiogenesis by antagonizing the
proangiogenic activity of Vegf (Zygmunt et al., 2011), and
Sema3e-Plxnd1 signaling affects retinal angiogenic cell fate de-
cisions by regulating cell responsiveness to Vegf and Notch in tip
and stalk cells (Kim et al., 2011).
However, Plxnd1 mutants have a more severe cardiovascular
phenotype that that of Sema3emutants, suggesting that Plxnd1
in endothelial cells may transduce signals from other semaphor-
ins. In support of this possibility, Plxnd1 in complex with Nrp1 or
Nrp2 is capable of binding to Sema3a, Sema3c, and Sema4a
in vitro (Gitler et al., 2004; Toyofuku et al., 2007). Plxnd1-deficient
endothelial cells fail to respond to Sema3a in Boyden chamber
and aortic ring assays (Zhang et al., 2009).
Semaphorins and the Vasculature. Multiple class 3 semaphor-
ins can modulate endothelial behavior. Sema3a signals throughCell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 169
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tion, adhesion, and capillary sprouting in aortic ring assays and
can modulate retinal neovascularization after injury as well as
vascular permeability (Acevedo et al., 2008; Joyal et al., 2011;
Miao et al., 1999). However, whether knockout of Sema3a
causes abnormalities of murine vascular development remains
controversial (Serini et al., 2003; Vieira et al., 2007). Sema3b re-
pels endothelial cells by binding to Nrp1, therefore functioning as
an angiogenesis inhibitor (Varshavsky et al., 2008). Sema3c in-
duces endothelial cell proliferation, adhesion, and migration
(Banu et al., 2006). Sema3d inhibits endothelial tube formation,
adhesion, and motility through Nrp1- and PI3K/Akt-dependent
pathways (Aghajanian et al., 2014). Sema3f inhibits adhesion of
endothelial cells to fibronectin and FGF-induced human umbili-
cal vein endothelial cell proliferation and survival (Kessler et al.,
2004; Serini et al., 2003). Sema3g acts as a positive regulator
of angiogenesis by stimulating endothelial cells and activating
smooth muscle cells (Kutschera et al., 2011).
Membrane-bound semaphorins possess both pro- and anti-
angiogenic properties during development and in pathological
conditions. For example, Sema4a binds to Plxnd1 and inhibits
developmental angiogenesis (Toyofuku et al., 2007), and
Sema4d signals via Plxnb1 on endothelial cells to regulate
motility (Yukawa et al., 2010). Sema5a signals through the recep-
tor Plxnb3 (Artigiani et al., 2004), andmice lacking Sema5a show
defective remodeling of cranial blood vessels. Branching of cra-
nial cardinal veins is reduced in Sema5a mutants compared to
controls (Fiore et al., 2005). Sema6a binds to Plxna2 and Plxna4
receptors (Suto et al., 2007) and regulates vascular development
and adult angiogenesis (Segarra et al., 2012). Interestingly, a sol-
uble form of Sema6a can inhibit angiogenesis (Dhanabal et al.,
2005) and cleaved forms of other semaphorins have been
described with altered angiogenic functions (Basile et al.,
2007; Casazza et al., 2010; Guo et al., 2013; Varshavsky et al.,
2008).
The role played by neuropilin receptors in the vasculature is
complicated by the fact that they can participate directly in
Vegf signaling by heterodimerizing with Vegfr2 (Kdr) (Kawasaki
et al., 1999; Lee et al., 2002; Soker et al., 1998). Nrp1 knockout
embryos display a wide range of vascular defects, and overex-
pression of Nrp1 leads to excessive formation of blood vessels
and capillaries (Kitsukawa et al., 1995). Nrp1 is strongly ex-
pressed on the newly formed vasculature during wound healing,
and blocking of Nrp1 signaling reduces vascular density within
the wound (Matthies et al., 2002). Nrp2-deficient mice are viable
(Chen et al., 2000; Giger et al., 2000), but Vegf-induced retinal
neovascularization is significantly compromised in Nrp2/
mice (Shen et al., 2004). Double Nrp1/Nrp2 knockout mice die
as early as E8.5 and display a more severe vasculature pheno-
type than single knockouts suggesting partial functional redun-
dancy (Takashima et al., 2002).
Lymphangiogenesis and Tumor Angiogenesis. Semaphorins,
plexins, and neuropilins have all been implicated in tumor angio-
genesis, a topic that has been the subject of several excellent
recent reviews (Ch’ng and Kumanogoh, 2010; Neufeld and
Kessler, 2008; Neufeld et al., 2012; Sakurai et al., 2012). Sema-
phorin ligands expressed by tumor cells and by tumor-associ-
ated immune cells can stimulate pro-angiogenic pathways in
endothelial cells, and the possibility of developing anti-angio-170 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.genic therapies for cancer by targeting these pathways is being
actively explored.
Sema3a and its receptors Nrp1, Nrp2, and Plxna1 are ex-
pressed in lymphatic vessels and participate in both lymphatic
valve formation and assembly of lymphatic vessels (Bouvre´e
et al., 2012; Jurisic et al., 2012). Sema3a, Plxna1, and
Nrp1sema/ knockout mice have small and poorly formed
lymphatic valves (Bouvre´e et al., 2012). Nrp2 knockout mice
have malformed lymphatic vessels and capillaries, but no
lymphatic valve defects (Yuan et al., 2002). Sema3a, and prob-
ably other membrane-bound and secreted semaphorins, can
participate in both lymphatic patterning and valve formation.
Defective lymphatic patterning and homeostasis can result in
significantmorbidity related to lymphedema and other complica-
tions, suggesting that a better understanding of the role of sem-
aphorins in lymphangiogenesis will be important for targeting
and minimizing side effects of potential therapies that target
semaphorin, plexin and neuropilin pathways.
Concluding Remarks
Since the discovery of semaphorins as axon-guidance mole-
cules, semaphorin signaling has emerged as an important
pathway in nearly every organ and tissue. The cardiovascular
system is no exception, and a wealth of data underscores the
critical role that semaphorins play during cardiovascular devel-
opment and in various disease processes. The complex code
that dictates which semaphorin ligands will interact with which
receptors to produce various outputs is only beginning to
emerge, and the complexity increases when we consider combi-
nations of heterodimeric receptors and interplay with related
signaling pathways. Abnormalities in semaphorin signaling com-
ponents account for developmental patterning defects and
congenital heart disease, and further elucidation of the mecha-
nisms by which semaphorins affect the vasculature offer oppor-
tunities for new pro- and anti-angiogenic therapies for cancer,
tissue ischemia, and other disorders.
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